Efficacy and toxicity profile of pegylated liposomal doxorubicin (Caelyx) in patients with advanced breast cancer

Gespeichert in:
Bibliographische Detailangaben
Weitere Verfasser: Rom, Joachim (BerichterstatterIn) , Marmé, Frederik (BerichterstatterIn) , Schütz, Florian (BerichterstatterIn) , Sohn, Christof (BerichterstatterIn) , Schneeweiss, Andreas (BerichterstatterIn) , Bechstein, Sarah (BerichterstatterIn) , Domschke, Christoph (BerichterstatterIn) , Golatta, Michael (BerichterstatterIn) , Mayer, Christine (BerichterstatterIn) , Heil, Jörg (BerichterstatterIn) , Thum, Janina (BerichterstatterIn) , Smetanay, Katharina (BerichterstatterIn) , Wallwiener, Markus (BerichterstatterIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2014
In: Anti-cancer drugs
Year: 2014, Jahrgang: 25, Heft: 2, Pages: 219-224
ISSN:1473-5741
DOI:10.1097/CAD.0000000000000037
Online-Zugang:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1097/CAD.0000000000000037
Volltext
Verfasserangaben:Rom, Joachim; Bechstein, Sarah; Domschke, Christoph; Golatta, Michael; Mayer, Christine; Heil, Joerg; Thum, Janina; Smetanay, Katharina; Windemuth-Kieselbach, Christine; Wallwiener, Markus; Marme, Frederik; Schuetz, Florian; Sohn, Christof; Schneeweiss, Andreas

MARC

LEADER 00000caa a2200000 c 4500
001 1482068044
003 DE-627
005 20230426123111.0
007 cr uuu---uuuuu
008 140821s2014 xx |||||o 00| ||eng c
024 7 |a 10.1097/CAD.0000000000000037  |2 doi 
024 7 |a 174374975  |2 swets 
035 |a (DE-627)1482068044 
035 |a (DE-576)412068044 
035 |a (DE-599)BSZ412068044 
035 |a (OCoLC)1340644267 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
084 |a 33  |2 sdnb 
245 0 0 |a Efficacy and toxicity profile of pegylated liposomal doxorubicin (Caelyx) in patients with advanced breast cancer  |c Rom, Joachim; Bechstein, Sarah; Domschke, Christoph; Golatta, Michael; Mayer, Christine; Heil, Joerg; Thum, Janina; Smetanay, Katharina; Windemuth-Kieselbach, Christine; Wallwiener, Markus; Marme, Frederik; Schuetz, Florian; Sohn, Christof; Schneeweiss, Andreas 
264 1 |c 2014 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 15.08.2014 
700 1 |a Rom, Joachim  |d 1975-  |0 (DE-588)130877018  |0 (DE-627)707590604  |0 (DE-576)298390833  |4 oth 
700 1 |a Marmé, Frederik  |d 1974-  |0 (DE-588)132561972  |0 (DE-627)52394893X  |0 (DE-576)299226549  |4 oth 
700 1 |a Schütz, Florian  |d 1972-  |0 (DE-588)12303387X  |0 (DE-627)082307229  |0 (DE-576)293528810  |4 oth 
700 1 |a Sohn, Christof  |d 1961-  |0 (DE-588)131349287  |0 (DE-627)507642902  |0 (DE-576)298422255  |4 oth 
700 1 |a Schneeweiss, Andreas  |d 1961-  |0 (DE-588)109972554  |0 (DE-627)632849630  |0 (DE-576)327251859  |4 oth 
700 1 |a Bechstein, Sarah  |d 1988-  |0 (DE-588)1052964079  |0 (DE-627)789426072  |0 (DE-576)408706597  |4 oth 
700 1 |a Domschke, Christoph  |d 1982-  |0 (DE-588)139103201  |0 (DE-627)703207679  |0 (DE-576)310245095  |4 oth 
700 1 |a Golatta, Michael  |d 1974-  |0 (DE-588)132350386  |0 (DE-627)521535727  |0 (DE-576)299091392  |4 oth 
700 1 |a Mayer, Christine  |d 1982-  |0 (DE-588)136998585  |0 (DE-627)589003909  |0 (DE-576)301383308  |4 oth 
700 1 |a Heil, Jörg  |d 1978-  |0 (DE-588)132580187  |0 (DE-627)52396160X  |0 (DE-576)299238679  |4 oth 
700 1 |a Thum, Janina  |d 1983-  |0 (DE-588)1052369685  |0 (DE-627)788453009  |0 (DE-576)408116625  |4 oth 
700 1 |a Smetanay, Katharina  |d 1982-  |0 (DE-588)140122036  |0 (DE-627)616034857  |0 (DE-576)314686452  |4 oth 
700 1 |a Wallwiener, Markus  |d 1980-  |0 (DE-588)134044827  |0 (DE-627)692043934  |0 (DE-576)27468327X  |4 oth 
773 0 8 |i In  |t Anti-cancer drugs  |d Hagerstown, Md. : Lippincott Williams & Wilkins, 1990  |g 25(2014), 2, Seite 219-224  |h Online-Ressource  |w (DE-627)320649652  |w (DE-600)2025803-3  |w (DE-576)094502161  |x 1473-5741  |7 nnas  |a Efficacy and toxicity profile of pegylated liposomal doxorubicin (Caelyx) in patients with advanced breast cancer 
773 1 8 |g volume:25  |g year:2014  |g number:2  |g pages:219-224  |g extent:6  |a Efficacy and toxicity profile of pegylated liposomal doxorubicin (Caelyx) in patients with advanced breast cancer 
856 4 0 |u http://dx.doi.org/10.1097/CAD.0000000000000037  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20140821 
993 |a Article 
994 |a 2014 
998 |g 109972554  |a Schneeweiss, Andreas  |m 109972554:Schneeweiss, Andreas  |d 910000  |d 910400  |e 910000PS109972554  |e 910400PS109972554  |k 0/910000/  |k 1/910000/910400/  |p 14  |y j 
998 |g 131349287  |a Sohn, Christof  |m 131349287:Sohn, Christof  |d 910000  |d 910400  |e 910000PS131349287  |e 910400PS131349287  |k 0/910000/  |k 1/910000/910400/  |p 13 
998 |g 12303387X  |a Schütz, Florian  |m 12303387X:Schütz, Florian  |d 910000  |d 910400  |d 50000  |e 910000PS12303387X  |e 910400PS12303387X  |e 50000PS12303387X  |k 0/910000/  |k 1/910000/910400/  |k 0/50000/  |p 12 
998 |g 132561972  |a Marmé, Frederik  |m 132561972:Marmé, Frederik  |d 910000  |d 910400  |e 910000PM132561972  |e 910400PM132561972  |k 0/910000/  |k 1/910000/910400/  |p 11 
998 |g 134044827  |a Wallwiener, Markus  |m 134044827:Wallwiener, Markus  |d 910000  |d 910400  |e 910000PW134044827  |e 910400PW134044827  |k 0/910000/  |k 1/910000/910400/  |p 10 
998 |g 140122036  |a Smetanay, Katharina  |m 140122036:Smetanay, Katharina  |d 910000  |d 910400  |e 910000PS140122036  |e 910400PS140122036  |k 0/910000/  |k 1/910000/910400/  |p 8 
998 |g 1052369685  |a Thum, Janina  |m 1052369685:Thum, Janina  |d 910000  |d 910400  |e 910000PT1052369685  |e 910400PT1052369685  |k 0/910000/  |k 1/910000/910400/  |p 7 
998 |g 132580187  |a Heil, Jörg  |m 132580187:Heil, Jörg  |d 910000  |d 910400  |e 910000PH132580187  |e 910400PH132580187  |k 0/910000/  |k 1/910000/910400/  |p 6 
998 |g 136998585  |a Mayer, Christine  |m 136998585:Mayer, Christine  |d 910000  |d 910400  |e 910000PM136998585  |e 910400PM136998585  |k 0/910000/  |k 1/910000/910400/  |p 5 
998 |g 132350386  |a Golatta, Michael  |m 132350386:Golatta, Michael  |d 910000  |d 910400  |e 910000PG132350386  |e 910400PG132350386  |k 0/910000/  |k 1/910000/910400/  |p 4 
998 |g 139103201  |a Domschke, Christoph  |m 139103201:Domschke, Christoph  |d 910000  |d 910400  |e 910000PD139103201  |e 910400PD139103201  |k 0/910000/  |k 1/910000/910400/  |p 3 
998 |g 1052964079  |a Bechstein, Sarah  |m 1052964079:Bechstein, Sarah  |d 910000  |e 910000PB1052964079  |k 0/910000/  |p 2 
998 |g 130877018  |a Rom, Joachim  |m 130877018:Rom, Joachim  |d 910000  |d 910400  |e 910000PR130877018  |e 910400PR130877018  |k 0/910000/  |k 1/910000/910400/  |p 1  |x j 
999 |a KXP-PPN1482068044  |e 2812190701 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1482068044","type":{"bibl":"article-journal","media":"Online-Ressource"},"relHost":[{"disp":"Efficacy and toxicity profile of pegylated liposomal doxorubicin (Caelyx) in patients with advanced breast cancerAnti-cancer drugs","part":{"volume":"25","issue":"2","text":"25(2014), 2, Seite 219-224","extent":"6","year":"2014","pages":"219-224"},"recId":"320649652","id":{"issn":["1473-5741"],"eki":["320649652"],"zdb":["2025803-3"]},"type":{"media":"Online-Ressource","bibl":"periodical"},"physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["1.1990 -"],"origin":[{"dateIssuedKey":"1990","publisherPlace":"Hagerstown, Md. ; [Erscheinungsort nicht ermittelbar]","publisher":"Lippincott Williams & Wilkins ; Ovid","dateIssuedDisp":"1990-"}],"language":["eng"],"note":["Gesehen am 17.10.05"],"title":[{"title":"Anti-cancer drugs","title_sort":"Anti-cancer drugs"}]}],"name":{"displayForm":["Rom, Joachim; Bechstein, Sarah; Domschke, Christoph; Golatta, Michael; Mayer, Christine; Heil, Joerg; Thum, Janina; Smetanay, Katharina; Windemuth-Kieselbach, Christine; Wallwiener, Markus; Marme, Frederik; Schuetz, Florian; Sohn, Christof; Schneeweiss, Andreas"]},"person":[{"display":"Rom, Joachim","given":"Joachim","family":"Rom","role":"oth"},{"display":"Marmé, Frederik","given":"Frederik","family":"Marmé","role":"oth"},{"given":"Florian","family":"Schütz","display":"Schütz, Florian","role":"oth"},{"role":"oth","display":"Sohn, Christof","given":"Christof","family":"Sohn"},{"family":"Schneeweiss","given":"Andreas","display":"Schneeweiss, Andreas","role":"oth"},{"role":"oth","display":"Bechstein, Sarah","given":"Sarah","family":"Bechstein"},{"role":"oth","given":"Christoph","family":"Domschke","display":"Domschke, Christoph"},{"role":"oth","display":"Golatta, Michael","given":"Michael","family":"Golatta"},{"role":"oth","family":"Mayer","given":"Christine","display":"Mayer, Christine"},{"role":"oth","display":"Heil, Jörg","given":"Jörg","family":"Heil"},{"given":"Janina","family":"Thum","display":"Thum, Janina","role":"oth"},{"display":"Smetanay, Katharina","given":"Katharina","family":"Smetanay","role":"oth"},{"display":"Wallwiener, Markus","family":"Wallwiener","given":"Markus","role":"oth"}],"language":["eng"],"origin":[{"dateIssuedKey":"2014","dateIssuedDisp":"2014"}],"title":[{"title":"Efficacy and toxicity profile of pegylated liposomal doxorubicin (Caelyx) in patients with advanced breast cancer","title_sort":"Efficacy and toxicity profile of pegylated liposomal doxorubicin (Caelyx) in patients with advanced breast cancer"}],"id":{"doi":["10.1097/CAD.0000000000000037"],"eki":["1482068044"]},"physDesc":[{"extent":"6 S."}],"note":["Gesehen am 15.08.2014"]} 
SRT |a EFFICACYAN2014